Introduction {#s1}
============

Depression is highly prevalent throughout the world population ([@bib41]). Clinically available antidepressants share the same core mechanisms of blocking serotonin and noradrenaline reuptake in the brain. However, a significant number of patients with depression do not fully respond to serotonin and/or noradrenaline reuptake inhibitors ([@bib1]). There is an increasing appreciation for the role of dopamine in the pathophysiology of depression ([@bib71]). Levels of dopamine metabolites in cerebrospinal fluid are reduced in depressive subjects ([@bib12]). There is a high incidence (30--50%) of comorbid depression in patients with Parkinson's disease ([@bib16]), which is characterized by the degeneration of midbrain dopaminergic neurons ([@bib2]). In patients with untreated Parkinson\'s disease, higher depression scores were associated with lower dopamine synthesis capacity in the striatum ([@bib40]). Additionally, in a double-blind clinical study, the dopamine receptor agonist pramipexole produced antidepressant effects in patients that failed to respond to standard antidepressant treatments ([@bib28]). Given the well-established role of dopamine in reward processing and motivation ([@bib13]; [@bib69]), and that anhedonia and lack of motivation are core symptoms of depression ([@bib25]; [@bib71]), it is thought that dysfunction of the dopamine reward system might contribute to anhedonia and the loss of motivation common in depression ([@bib71]).

Chronic mild unpredictable stress (CMS) ([@bib95]) and chronic social defeat stress (CSDS) ([@bib7]; [@bib32]; [@bib47]; [@bib48]) are well-established rodent models of depression. However, CMS and CSDS induce opposing changes in ventral tegmental area (VTA) dopamine neuron activity: CMS reduced action potential (AP) firing in VTA dopamine neurons ([@bib19]; [@bib70]; [@bib88]), whereas susceptibility to CSDS was accompanied by an increase in AP firing ([@bib17]; [@bib20]; [@bib47]; [@bib49]). The behavioral effects of optogenetically activating or inhibiting VTA dopamine neurons also differ between mice subject to CMS or CSDS. In the CSDS model, optogenetic phasic stimulation of VTA neurons that project to the nucleus accumbens (NAc) induced susceptibility to social defeat, whereas optogenetic inhibition of the VTA--NAc projection induced resilience ([@bib20]). In contrast, optogenetic phasic stimulation of VTA dopamine neurons reversed CMS-induced depressive-like behavior, while optogenetic inhibition of VTA dopamine neurons induced behavioral despair and decreased sucrose preference in stress-naïve mice ([@bib88]). Thus, modulating VTA dopamine neuron firing can enhance or prevent the development of depression-like behavior, and potential factors that might explain these divergent results have been contemplated ([@bib37]; [@bib53]).

AP firing in VTA dopamine neurons is governed by multiple voltage-dependent ionic conductances, including the hyperpolarization-activated cation current (I~h~), which is generated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels ([@bib66]; [@bib73]). There are four subtypes of HCN (HCN1-4), which mainly form homotetramers with distinct properties ([@bib91]) and have different brain distributions ([@bib72]). Although *Hcn1-4* mRNAs are expressed in the VTA ([@bib67]), immunostaining for HCN protein has shown that HCN2 is the predominant HCN subunit expressed in the VTA ([@bib72]). Tetratricopeptide repeat-containing Rab8b-interacting protein (TRIP8b) is an auxiliary subunit of HCN1-4 channels and is required for HCN trafficking and enrichment at dendrites ([@bib34]; [@bib55]; [@bib56]; [@bib82]). Global knockout of *Hcn1* or *Trip8b* reduced behavioral despair, but these mice did not display anxiolytic-like behaviors ([@bib56]), while lentivirus-mediated shRNA knockdown of HCN1 in the dorsal hippocampus promoted both anxiolytic- and antidepressant-like effects ([@bib43]; [@bib42]). The antidepressant-like effects of global *Trip8b* knockout can be reversed by reinstating TRIP8b expression in the dorsal hippocampus ([@bib35]; [@bib59]). Apathetic (*Hcn2^ap/ap^*) mice with a spontaneous null mutation in *Hcn2* show reduced behavioral despair in the tail suspension test, but these mice exhibit deficits in motor coordination and locomotion and cannot perform the forced swim test due to an inability to swim ([@bib56]). Thus, HCN channels can be powerful regulators of depressive- and anxiety-like behaviors, and different HCN isoforms in different brain regions may play distinct roles in regulating rodent behavior.

The I~h~ current generates pacemaker activity via permeability to cations ([@bib8]), and enhancing I~h~ current increases AP firing in VTA dopamine neurons ([@bib29]; [@bib66]; [@bib73]). CSDS leads to an increase in I~h~ current in VTA dopamine neurons in susceptible mice, and an even further increase in I~h~ current in resilient mice, but normal AP firing is achieved in resilient mice via homeostatic upregulation of voltage-gated K^+^ currents ([@bib17]; [@bib29]). Overexpression of HCN2 in VTA dopamine neurons or intra-VTA infusion of an I~h~ potentiator in susceptible animals produced a reversal of social avoidance behavior, likely by a homeostatic upregulation of K^+^ current and the subsequent normalization of AP firing ([@bib29]). However, given that CMS and CSDS induce distinct neuroadaptations in VTA dopamine neurons ([@bib20]; [@bib37]; [@bib53]; [@bib88]), in particular the observation that CMS leads to decreased VTA dopamine neuron firing, it is of interest to investigate whether CMS alters I~h~ current in VTA dopamine neurons, and if so, whether the alteration of I~h~ current contributes to the development of depressive-like behaviors.

VTA dopamine neurons are heterogeneous in their projection targets and HCN expression ([@bib30]; [@bib69]). In mice, neurons that project to the lateral shell of the NAc display large I~h~ current, whereas those that project to the medial prefrontal cortex (mPFC), medial shell of the NAc, or basolateral amygdala exhibit minimal I~h~ current ([@bib4]; [@bib50]; [@bib51]). Dopamine neurons projecting to the lateral shell of the NAc are thought to signal primary reward and salience ([@bib15]; [@bib51]), and optogenetic stimulation of an excitatory input to dopamine neurons projecting to the NAc lateral shell elicits reward ([@bib52]). Thus, in the present study, we investigated how CMS affects I~h~ current in VTA dopamine neurons that project to the lateral shell of the NAc. Furthermore, we determined whether virus-mediated knockdown or overexpression of HCN2 in the VTA affects depression- and anxiety-like behaviors. We provide evidence that CMS led to a decrease in I~h~ current in NAc lateral shell-projecting VTA dopamine neurons, and that manipulating HCN2 expression in the VTA can powerfully regulate depressive- and anxiety-like behavior.

Results {#s2}
=======

CMS induced depressive and anxiety-like behavior {#s2-1}
------------------------------------------------

About equal numbers of C57BL/6J and DAT-tdTomato reporter mice (generated by crossing *Slc6a3^Cre+/−^* mice with Ai9 mice; see Materials and methods) were exposed to a variety of mild stressors in an unpredictable manner for 5 weeks (CMS group), while age-matched, stress-naïve C57BL/6J and DAT-tdTomato littermates served as corresponding control groups, and did not receive any special treatments except normal handling and behavioral tests. We have previously shown that mice exposed to CMS for 5 weeks exhibit depressive-like behaviors ([@bib93]; [@bib98]; [@bib99]), which can be reversed by chronic treatments with the antidepressant fluoxetine ([@bib93]). C57BL/6J mice and DAT-tdTomato mice are on the same genetic background, and because there were no significant differences between these groups in the various behavioral tests ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}), the results were pooled ([Figure 1](#fig1){ref-type="fig"}). C57BL/6J mice were later used for in vivo electrophysiology and DAT-tdTomato mice were later used for ex vivo slice electrophysiology because the latter allowed unambiguous identification of VTA dopamine neurons (see below). The timeline of CMS, behavioral tests, and electrophysiology is listed in [Figure 1A](#fig1){ref-type="fig"}.

![CMS produced depressive- and anxiety-like behaviors.\
(**A**) The timeline of CMS, behavioral tests, and electrophysiology. (**B**) CMS significantly decreased body weight compared with non-stressed control mice (\*\*p=0.004, control, n = 14 mice; CMS n = 12 mice from **B** to **G**). (**C**) CMS significantly decreased the center time (\*\*p=0.007) without affecting total distance traveled in the OFT (p=0.615). (**D**) CMS significantly decreased sucrose preference compared to control (\*\*\*p\<0.001). (**E**) CMS did not affect entries into the open arms (p=0.919), but significantly decreased the time spent in the open arms (\*p=0.036) in the EPM test. (**F**) CMS significantly increased the latency to feed in the novel environment (Novelty) in the NSF test (\*\*p=0.008) but did not significantly affect the latency to feed in the home cage (Home) (p=0.345). (**G**) CMS significantly increased immobility time in the FST (\*\*\*p\<0.001).\
10.7554/eLife.32420.004Figure 1---source data 1.Body weight and behavior following CMS in [Figure 1B--G](#fig1){ref-type="fig"}.](elife-32420-fig1){#fig1}

Consistent with our previous study ([@bib93]), we found that body weight of the CMS group was significantly decreased compared with control mice (*t*~24~ = 3.2, p=0.004; [Figure 1B](#fig1){ref-type="fig"}). We then examined whether CMS leads to depressive- and anxiety-like behavior. First, to assess whether CMS-exposed mice exhibit anxiety-related behavior or altered locomotor activity, we used the open field test (OFT). Mice tend to avoid open spaces, and reduced time spent in the center of an open field has been correlated with anxiety- and depression-like behaviors in rodents ([@bib26]). There was no significant difference between control and CMS groups in the total distance travelled (*t*~24~ = 0.5, p=0.615; [Figure 1C](#fig1){ref-type="fig"}); in contrast, the time spent in the center square of the open field was significantly decreased in the CMS group (*t*~24~ = 2.9, p=0.007; [Figure 1C](#fig1){ref-type="fig"}). Second, the sucrose preference test (SPT) was performed to assess anhedonia, a core symptom of depression ([@bib25]). CMS significantly decreased sucrose preference compared with control mice (*t*~24~ = 4.6, p\<0.001; [Figure 1D](#fig1){ref-type="fig"}). Third, the elevated plus maze (EPM) test was carried out. A decrease in entries into and/or time spent in the open arms indicates anxiety-like behavior ([@bib45]; [@bib79]). CMS did not affect entries into the open arms (*t*~24~ = 0.1, p=0.919; [Figure 1E](#fig1){ref-type="fig"}), but significantly decreased the time spent in the open arms (*t*~24~ = 2.2, p=0.036; [Figure 1E](#fig1){ref-type="fig"}). Fourth, to assess depressive- and anxiety-like behavior, we used the novelty-suppressed feeding (NSF) test ([@bib80]). An increase in the latency to feed on food in the center of a novel open field is indicative of anxiety- and depressive-like behavior. CMS significantly increased the latency to feed in the novel environment (*t*~24~ = 2.9, p=0.008; [Figure 1F](#fig1){ref-type="fig"}), but did not alter the latency to feed in the home cage (*t*~24~ = 1.0, p=0.345; [Figure 1F](#fig1){ref-type="fig"}). Thus, the CMS-induced increase in the latency to feed in the novel environment cannot be explained by possible changes in appetite. Finally, the forced swim test (FST) was carried out. An increase in the immobility time in the FST suggests behavioral despair and depression ([@bib77]). CMS significantly increased immobility time in the FST (*t*~24~ = 5.5, p\<0.001; [Figure 1G](#fig1){ref-type="fig"}). Taken together, these results indicate that CMS leads to depressive- and anxiety-like behaviors.

CMS induced a decrease in AP firing in vivo in VTA dopamine neurons {#s2-2}
-------------------------------------------------------------------

We examined whether AP firing in VTA dopamine neurons in vivo was altered in CMS-exposed C57BL/6J mice. One day after the last behavioral test, CMS-exposed mice and time-matched control mice (C57BL/6J) were anesthetized with urethane and placed in a stereotaxic frame, and in vivo single-unit recordings were made in the VTA using stereotaxic coordinates (AP −2.9 to −3.3 mm, ML 0.6 to 1.1 mm, DV −3.9 to −4.5 mm) ([@bib75]) (see Materials and Methods). These coordinates targeted dopamine neurons in the lateral parabrachial pigmented nucleus (PBP), a subdivision of the VTA where dopamine neurons predominantly project to the lateral shell of the NAc, exhibit a large I~h~ current ([@bib50]; [@bib51]), and are critically involved in reward and motivated behavior ([@bib51]; [@bib52]). Dopamine neurons were identified by a broad, triphasic AP of a width greater than 2 ms and a relatively slow firing rate (\<10 Hz) ([Figure 2A](#fig2){ref-type="fig"}) ([@bib90]; [@bib89]). Dopamine neurons and recording locations were further validated post-mortem via juxtacellular labelling with neurobiotin and tyrosine hydroxylase (TH, a marker for dopamine neurons) immunostaining ([@bib20]; [@bib89]) ([Figure 2B](#fig2){ref-type="fig"}). Consistent with the electrophysiological criteria for identifying dopamine neurons ([@bib90]; [@bib89]), all neurobiotin-labeled neurons (control, n = 4; CMS, n = 5) we identified as dopamine neurons electrophysiologically were TH^+^ (control, n = 4 mice; CMS, n = 5 mice). Thus, the waveform identification of the remaining putative dopamine neurons is likely sufficiently accurate. We found that the number of firing dopamine neurons encountered per electrode track ('population activity') was significantly decreased in CMS-exposed mice (*t*~7~ = 7.3, p\<0.001; [Figure 2C](#fig2){ref-type="fig"}), as well as the average AP firing rate in each neuron (*t*~30~ = 2.1, p=0.045; [Figure 2A,D](#fig2){ref-type="fig"}). The proportion of spikes occurring within bursts was decreased in CMS-exposed mice (*t*~21~ = 3.1, p=0.006; [Figure 2A,E](#fig2){ref-type="fig"}). Thus, CMS decreased the population activity, as well as the average AP firing rate and the proportion of spikes occurring in bursts. The CMS-induced decrease in the population activity implies that the relative number of spontaneously firing dopamine neurons is decreased.

![CMS decreased single-unit AP firing in VTA dopamine neurons in vivo.\
(**A**) Sample traces of VTA dopamine neuron AP firing in control and CMS mice. Dopamine neurons were identified by a broad triphasic extracellular action potential of a width greater than 2 ms and a relatively slow firing rate (\<10 Hz). (**B**) A recorded dopamine neuron was confirmed by neurobiotin (red) and TH (tyrosine hydroxylase, green) co-localization. (**C--E**) Population activity (**C**, \*\*\*p\<0.001, control, n = 4 mice; CMS n = 5 mice), firing rate (**D**) \*p=0.045, control, n = 15 cells from four mice; CMS, n = 17 cells from five mice), and the percent of spikes in burst (**E**, \*\*p=0.006, control, n = 10 cells from four mice; CMS, n = 13 cells from five mice) were decreased in CMS mice.\
10.7554/eLife.32420.006Figure 2---source data 1.In vivo VTA dopamine neuron firing following CMS in [Figure 2C--E](#fig2){ref-type="fig"}.](elife-32420-fig2){#fig2}

CMS decreased I~h~ current and AP firing in VTA dopamine neurons ex vivo {#s2-3}
------------------------------------------------------------------------

The hyperpolarization-activated cation current (I~h~), mediated by HCN channels ([@bib8]), generates pacemaker activity and can drive AP firing in VTA dopamine neurons ([@bib66]; [@bib73]). We examined whether alteration of I~h~ current contributes to the CMS-induced decrease in AP firing. Although electrophysiological characteristics can reliably identify dopamine neurons in vivo ([@bib90]; [@bib89]), electrophysiological criteria such as the presence of I~h~ current are likely not sufficient for the identification of VTA dopamine neurons in brain slices ([@bib64]; [@bib63]). To overcome this limitation, we bred *Slc6a3^Cre+/−^* (DAT-Cre) mice with Ai9 reporter mice, which express tdTomato in the presence of Cre ([@bib60]), to produce DAT-tdTomato reporter mice. Some TH-Cre driver lines are poorly specific for dopamine neurons in mice ([@bib54]), and thus were not used. Immunofluorescence staining indicated that tdTomato was overlapped with TH ([Figure 3A](#fig3){ref-type="fig"}), indicating that tdTomato-positive neurons are exclusively dopamine neurons.

![Retrobead labeling of VTA dopamine neurons that project to the lateral shell of the NAc.\
(**A**) DAT-Cre mice were bred with Ai9 reporter mice, which express tdTomato in the presence of Cre, to produce DAT-tdTomato mice. TdTomato and TH (green) were completely co-localized, indicating that tdTomato expression provides faithful reporting of dopamine neurons for slice physiology. (**B**) Green Retrobeads were injected into the lateral shell of the NAc (LAcbSh) in DAT-tdTomato mice. (**C**) The Retrobeads were retrogradely transported to the VTA and were predominantly co-localized with tdTomato-positive VTA dopamine neurons.](elife-32420-fig3){#fig3}

VTA dopamine neurons that project to the lateral shell of the NAc exhibit a large I~h~ current and play a primary role in reward encoding ([@bib4]; [@bib15]; [@bib50]; [@bib51]; [@bib52]). Thus, we selectively performed slice electrophysiological recordings in these neurons. This was achieved by microinjecting green Retrobeads in the NAc lateral shell of DAT-tdTomato mice ([Figure 3B](#fig3){ref-type="fig"}) (see Materials and methods). Consistent with previous studies using TH staining ([@bib51]), we found that Retrobead-labeled neurons predominantly (95.7 ± 1.1%, n = 3 mice) were co-localized with tdTomato ([Figure 3C](#fig3){ref-type="fig"}), suggesting that the vast majority of VTA neurons projecting to the NAc lateral shell are dopamine neurons.

We investigated whether CMS altered I~h~ current in NAc lateral shell-projecting VTA dopamine neurons from DAT-tdTomato reporter mice. I~h~ current was recorded from neurons co-labeled with tdTomato (dopamine neurons) and green Retrobeads (neurons that project to the NAc lateral shell). I~h~ current was induced by hyperpolarizing voltage steps (from −60 mV to −130 mV with −10 mV steps, 1.5 s duration) followed by a step to −130 mV for analysis of tail currents. I~h~ amplitude, calculated by subtracting the instantaneous current (I~ins~) from the steady-state current ([Figure 4A](#fig4){ref-type="fig"}), was significantly decreased in dopamine neurons from CMS-exposed mice at hyperpolarization steps to −90 mV or greater (amplitude: −90 mV, *t*~26~ = 2.6, p=0.014; −100 mV, *t*~26~ = 3.6, p=0.001; −110 mV, *t*~26~ = 3.7, p\<0.001; −120 mV, *t*~26~ = 3.8, p\<0.001; −130 mV, *t*~26~ = 4.7, p\<0.001; [Figure 4A,B](#fig4){ref-type="fig"}). This cannot be attributed to differences in cell size, since membrane capacitance (C~m~) was not significantly different between control (50.9 ± 3.9 pF) and CMS mice (45.7 ± 2.2 pF, *t*~26~ = 1.1, p=0.273; [Figure 4C](#fig4){ref-type="fig"}), and I~h~ density, defined as I~h~ amplitude at −130 mV normalized to cell capacitance, was significantly decreased in CMS mice compared with control mice (*t*~26~ = 2.8, p=0.009; [Figure 4D](#fig4){ref-type="fig"}).

![CMS decreased I~h~ currents in VTA dopamine neurons that project to the lateral shell of the NAc (LAcbSh).\
(**A**) *Left*: Voltage protocol for recording I~h~ current. *Right*: Representative I~h~ current recorded from NAc-projecting VTA dopamine neurons in control and CMS mice. (**B**) Compared with the control group, I~h~ amplitude was significantly decreased in the CMS group at corresponding hyperpolarization potentials (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, control, n = 15 cells from five mice; CMS, 13 cells from three mice from **B** to **G**). I~h~ amplitude was calculated by subtracting the instantaneous current from the steady-state current achieved during the voltage step. (**C**) The membrane capacitance (C~m~) was not significantly different between control and CMS mice (p=0.273). (**D**) I~h~ current density was significantly decreased in the CMS group compared with the control group (\*\*p=0.009). (**E**) I~h~ activation curves in the control and CMS groups generated by the tail current protocol. Tail current amplitudes were fitted with a Boltzmann function. (**F**) CMS led to a significant hyperpolarizing shift of the half-activation potential (*V*~1/2~) compared with that of control (\*\*p=0.007). (**G**) The resting membrane conductance (G~resting~) was not significantly different between control and CMS mice (p=0.107).\
10.7554/eLife.32420.010Figure 4---source data 1.I~h~ amplitude and activation properties in VTA dopamine neurons following CMS in [Figure 4B--G](#fig4){ref-type="fig"}.](elife-32420-fig4){#fig4}

To assess potential differences in I~h~ activation properties, tail current amplitudes were plotted as a function of test potentials and were fitted with a Boltzmann function to produce I~h~ activation curves for both the control and CMS groups ([Figure 4A,E](#fig4){ref-type="fig"}). CMS significantly shifted the half-activation potential (V~1/2~) to a more hyperpolarized potential (*t*~26~ = 2.9, p=0.007; [Figure 4F](#fig4){ref-type="fig"}). Thus, CMS led to a significant reduction in I~h~ current in NAc lateral shell-projecting VTA dopamine neurons, as well as a hyperpolarizing shift in the half-activation potential of I~h~.

We measured the amplitude of I~ins~ and plotted this current against the hyperpolarizing voltage steps. The slope of these I-V curves provides an approximation of the resting membrane conductance (G~resting~) of the recorded neuron ([@bib4]; [@bib44]) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Although there was a trend toward a decrease in G~resting~ in the CMS group compared with that of control, the difference did not reach statistical significance (*t*~26~ = 1.7, p=0.107; [Figure 4G](#fig4){ref-type="fig"}). Thus, CMS leads to a decrease in I~h~ current without significantly changing the resting membrane conductance.

Pharmacological manipulations that increase I~h~ current lead to an increase in AP firing in VTA dopamine neurons ([@bib29]; [@bib92]), whereas the HCN blocker ZD7288 decreases AP firing in VTA dopamine neurons ([@bib66]; [@bib73]). If CMS indeed leads to decreased I~h~ current in dopamine neurons, and the CMS-induced decrease in I~h~ current contributes to the decrease in AP firing observed in vivo, then an HCN blocker should produce a greater suppression of AP firing in control mice than CMS mice. Thus, we investigated the effects of the HCN channel inhibitor ZD7288 on I~h~ current and VTA dopamine neuron AP firing. I~h~ current was abolished by the HCN channel blocker ZD7288 (30 μM) in both the control group (*t*~10~ = 7.6, p\<0.001) and the CMS group (*t*~10~ = 5.8, p\<0.001; [Figure 5A](#fig5){ref-type="fig"}). We then determined whether ZD7288 altered AP firing rate in these two groups. Dopamine neurons ex vivo fire spontaneous, regular APs that lack bursting activity ([@bib39]; [@bib65]), which may be attributable to the severing of excitatory afferent inputs during slice cutting. Nevertheless, cell-attached AP recordings were made in NAc-projecting VTA dopamine neurons in the presence of CNQX (10 µM), AP-5 (20 µM) and picrotoxin (50 µM) to block excitatory and inhibitory synaptic transmission, thus helping to isolate cell-autonomous effects which may influence AP firing. Two-way ANOVA showed that CMS and ZD7288 had significant effects on the mean firing rate (CMS, *F*~1,47~ = 13.7, p\<0.001; ZD7288, *F*~1,47~ = 28.6, p\<0.001), with a significant interaction between CMS and ZD7288 (*F*~1,47~ = 5.9, p=0.019; [Figure 5B,C](#fig5){ref-type="fig"}). Tukey's *post hoc* tests indicated that the mean firing rate was significantly decreased in the CMS group compared with the control group in vehicle-treated slices (p\<0.001). Further, ZD7288 (30 μM) significantly decreased AP firing in both control (p\<0.001) and CMS-exposed groups (p\<0.05). The mean firing rate was not significantly different between control and CMS-exposed groups in the presence of ZD7288 (p=0.382; [Figure 5C](#fig5){ref-type="fig"}). The firing rate (FR) suppression (%) in the control group was significantly higher than that of the CMS-exposed group (*t*~21~ = 3.2, p=0.004; [Figure 5D](#fig5){ref-type="fig"}). These results indicate that CMS exposure leads to decreased I~h~ currents in NAc lateral shell-projecting VTA dopamine neurons, and that this likely contributes to the CMS-induced decrease in AP firing.

shRNA knockdown of HCN2 in the VTA produced depressive- and anxiety-like behavior {#s2-4}
---------------------------------------------------------------------------------

We asked whether the CMS-induced decrease in I~h~ current in VTA dopamine neurons contributes to depressive- and anxiety-like behavior. To mimic HCN current downregulation, we used an RNA interference technique to knock down HCN2 in the VTA, which is the predominant HCN isoform in the VTA as determined via immunostaining ([@bib72]). AAV2-HCN2-shRNA-eGFP, which expresses a short hairpin RNA (shRNA) targeting *Hcn2* mRNA, or AAV2-scramble-shRNA-eGFP was microinjected into the VTA bilaterally in C57BL/6J mice and DAT-tdTomato mice. Three weeks after the AAV injections, immunofluorescence staining from C57BL/6J mice was performed. AAV2-scramble-shRNA-eGFP was expressed in 86.1 ± 5.1% of TH^+^ dopamine neurons in the VTA, while AAV2-HCN2-shRNA-eGFP was expressed in 83.9 ± 6.3% of TH^+^ dopamine neurons, as shown by co-labeling of eGFP with TH in the VTA ([Figure 6A,B,C](#fig6){ref-type="fig"}).

![, CMS decreased AP firing in VTA dopamine neurons in midbrain slices.\
(**A**) I~h~ currents recorded at −130 mV in NAc-projecting VTA dopamine neurons in both control (\*\*\*p\<0.001, n = 6 cells from three mice) and CMS groups (\*\*\*p\<0.001, n = 6 cells from three mice) were abolished by the I~h~ channel blocker ZD7288 (30 μM). (**B**) Representative AP firing in cell-attached recordings from NAc-projecting VTA dopamine neurons in control and CMS slices before and after ZD7288 (30 µM). (**C**) The AP firing rate was significantly decreased in the CMS group (n = 13 cells from three mice) compared with the control group (n = 12 cells from four mice; \*\*\*p\<0.001). ZD7288 significantly decreased the firing rate in both control (n = 11 cells from three mice) and CMS (n = 12 cells from five mice) groups (\*p\<0.5, \*\*\*p\<0.001). The mean firing rate was not significantly different between control (n = 11 cells from three mice) and CMS (n = 12 cells from four mice) groups following ZD7288 (p=0.382). (**D**) The firing rate (FR) suppression (%) by ZD7288 in the control group (n = 11 cells from three mice) was significantly higher than that of the CMS group (n = 12 cells from five mice; \*\*p=0.004).\
10.7554/eLife.32420.012Figure 5---source data 1.Effects of ZD7288 on I~h~ current and ex vivo AP firing in VTA dopamine neurons following CMS in [Figure 5A,C,D](#fig5){ref-type="fig"}.](elife-32420-fig5){#fig5}

![AAV-mediated shRNA knockdown of HCN2 in the VTA.\
(**A,B**), Immunofluorescence labeling showing the expression of AAV2-HCN2-shRNA-eGFP (green), TH (dopamine neuron marker, red) and NeuN (neuronal marker, blue) in the midbrain under low magnification (**A**) and high magnification (**B**). Scale bars: 50 µm. (**C**), The percentage of TH^+^ VTA dopamine neurons that were infected with AAV2-HCN2-shRNA-eGFP or scramble-shRNA (n = 3 mice/group). (**D**), Maximal I~h~ current amplitude was significantly decreased in AAV2-HCN2-shRNA-eGFP-infected dopamine neurons (n = 14 from three mice) compared with AAV2-scramble-shRNA-eGFP-infected dopamine neurons (n = 15 from four mice; \*\*\*p\<0.001). (**E**), AP firing frequency was decreased in AAV2-HCN2-shRNA-GeFP-infected neurons (n = 10 from three mice) compared with AAV2-scramble-shRNA-eGFP-infected neurons (n = 9 from four mice; \*p=0.036).\
10.7554/eLife.32420.015Figure 6---source data 1.I~h~ current and AP firing following shRNA-mediated HCN2 knockdown in [Figure 6C--E](#fig6){ref-type="fig"}.](elife-32420-fig6){#fig6}

To determine whether AAV2-HCN2-shRNA-eGFP was effective in knocking down HCN2 in the VTA, we made whole-cell recordings from eGFP and tdTomato co-expressing dopamine neurons in the lateral PBP. I~h~ current was greatly attenuated in cells infected with AAV2-HCN2-shRNA-eGFP compared with cells infected with AAV2-scramble-shRNA-eGFP, as shown by a significant decrease in the maximal magnitude of I~h~ current at −130 mV (*t*~27~ = 8.3, p\<0.001; [Figure 6D](#fig6){ref-type="fig"}). The resting conductance (G~resting~) was significantly decreased following HCN2 knockdown (*t*~27~ = 2.4, p=0.022; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), suggesting that I~h~ current may also make a modest contribution to the instantaneous inward currents (I~ins~). The AP firing rate of dopamine neurons in slices prepared from AAV2-HCN2-shRNA-eGFP-injected mice were also significantly decreased compared with that of AAV2-scramble-shRNA-eGFP-injected mice (*t*~17~ = 2.3, p=0.036, [Figure 6E](#fig6){ref-type="fig"}).

Having confirmed the effectiveness of shRNA knockdown of HCN2 in the VTA, we next determined whether HCN2 in the VTA regulates depressive- and anxiety-like behaviors. Behavioral tests were conducted in C57BL/6J mice that received intra-VTA injection of AAV2-scramble-shRNA-eGFP or AAV2-HCN2-shRNA-eGFP three weeks prior. Compared with control (scramble-shRNA) mice, the body weight of the HCN2-shRNA group was not significantly different (*t*~12~ = 0.4, p=0.727; [Figure 7A](#fig7){ref-type="fig"}). In the OFT, the total distance travelled was not significantly different (*t*~12~ = 1.4, p=0.197; [Figure 7B](#fig7){ref-type="fig"}), but the time spent in the center square of the open field was significantly decreased in the HCN2-shRNA group (*t*~12~ = 2.9, p=0.042; [Figure 7B](#fig7){ref-type="fig"}). The HCN2-shRNA group also showed a significant decrease in sucrose preference (*t*~12~ = 3.7, p=0.003; [Figure 7C](#fig7){ref-type="fig"}). In the EPM test, there was no significant difference in the entries into the open arms (*t*~12~ = 1.8, p=0.104; [Figure 7D](#fig7){ref-type="fig"}), but the time spent in the open arms was significantly decreased in the HCN2-shRNA group (*t*~12~ = 2.7, p=0.018; [Figure 7D](#fig7){ref-type="fig"}). In the NSF test, the HCN2-shRNA group exhibited a significant increase in the latency to feed in the novel environment (*t*~12~ = 2.8, p=0.017; [Figure 7E](#fig7){ref-type="fig"}), with no significant difference in the latency to feed in the home cage (*t*~12~ = 0.6, p=0.583; [Figure 7E](#fig7){ref-type="fig"}). In the FST, the HCN2-shRNA group showed a significant increase in immobility time (*t*~12~ = 2.3, p=0.039; [Figure 7F](#fig7){ref-type="fig"}). Taken together, these results indicate that shRNA knockdown of HCN2 in the VTA is sufficient to recapitulate the depressive- and anxiety-like behaviors seen following CMS exposure.

![ShRNA knockdown of HCN2 in the VTA produced anxiety- and depressive-like behaviors.\
(**A**) VTA-specific HCN2 knockdown did not significantly affect the body weight of mice (control, n = 7 mice; CMS, n = 7 mice; p=0.727). (**B**) HCN2 knockdown significantly decreased the center time (\*p=0.042) without affecting the total distance traveled (p=0.197) in the OFT. (**C**) HCN2 knockdown significantly decreased sucrose preference (\*\*p=0.003). (**D**) HCN2 knockdown did not affect entries into the open arms (p=0.104) but significantly decreased time spent in the open arms (\*p=0.018) in the EPM test. (**E**) HCN2 knockdown increased the latency to feed in the novel environment (Novelty) in the NSF test (\*p=0.017) but did not significantly affect the latency to feed in the home cage (Home; p=0.583). (**F**) HCN2 knockdown increased immobility time in the FST (\*p=0.039).\
10.7554/eLife.32420.017Figure 7---source data 1.Body weight and behavior following VTA HCN2 knockdown in [Figure 7A--F](#fig7){ref-type="fig"}.](elife-32420-fig7){#fig7}

Overexpression of HCN2 in the VTA prevented the development of CMS-induced depressive-like behavior {#s2-5}
---------------------------------------------------------------------------------------------------

We have shown that CMS led to a decrease in I~h~ current in VTA dopamine neurons, while shRNA knockdown of HCN2 recapitulated the depression- and anxiety-like behavioral effects of CMS. We next determined whether overexpression of HCN2 in the VTA could prevent the development of behavioral deficits produced by CMS. DAT-tdTomato mice received bilateral intra-VTA injections of AAV2-HCN2-eGFP or AAV2-eGFP. Three weeks after the AAV microinjections, midbrain slices were prepared and I~h~ current was recorded. We found that I~h~ current amplitude in HCN2-expressing dopamine neurons was significantly increased compared with eGFP-expressing dopamine neurons (*t*~27~ = 3.3, p=0.002; [Figure 8A](#fig8){ref-type="fig"}). Thus, overexpression of HCN2 produces gain-of-function of I~h~ current in the VTA.

![Overexpression of HCN2 in the VTA prevented the development of CMS-induced depressive-like behavior.\
(**A**) The maximal amplitude of I~h~ current in AAV2-HCN2-eGFP-infected VTA dopamine neurons (n = 15 from four mice) was significantly increased compared with that in AAV2-eGFP-infected VTA dopamine neurons (n = 14 cells from five mice; \*\*p=0.002). (**B**) CMS significantly decreased the body weight of mice in the AAV2-eGFP injection group (\*\*\*p\<0.001, control, n = 9 mice; CMS, n = 10 mice from **B** to **G**), whereas CMS did not decrease the body weight of mice in the HCN2 overexpression group (p=0.419, control, n = 10 mice; CMS, n = 8 mice from **B** to **G**). (**C**) Neither CMS nor HCN2 overexpression affected the total distance traveled in the OFT test (p\>0.05). Compared with non-stressed control mice, CMS significantly decreased the time spent in the center square of the open field in the AAV2-eGFP group (\*\*p=0.002), and this decrease was prevented by HCN2 overexpression (\*\*p=0.004). (**D**) CMS significantly decreased sucrose preference in the AAV2-eGFP injection group (\*\*\*p\<0.001), whereas HCN2 overexpression prevented this decrease (\*\*\*p\<0.001). (**E**) In the AAV2-GFP group, CMS significantly decreased time spent in the open arms (\*p=0.023) but did not affect open arm entries (p\>0.05). HCN2 overexpression did not significantly affect open arm time nor entries (p=0.057) compared to the AAV2-GFP group. (**F**) CMS induced a significant increase in the latency to feed in the novel environment in the NSF test (\*\*p=0.002), which was prevented by HCN2 overexpression (\*\*p=0.001). Neither CMS nor HCN2 overexpression affected the latency to feed in the home cage (p\>0.05). (**G**) CMS produced a significant increase in immobility in the FST (\*\*\*p\<0.001), and this increase was prevented by HCN2 overexpression (\*\*\*p\<0.001).\
10.7554/eLife.32420.019Figure 8---source data 1.VTA HCN2 overexpression effects on I~h~ current and CMS-induced changes in body weight and behavior in [Figure 8A--G](#fig8){ref-type="fig"}.](elife-32420-fig8){#fig8}

Having demonstrated the effectiveness of HCN2 overexpression in enhancing I~h~ current, we next examined the effects of VTA HCN2 overexpression on depression- and anxiety-related behaviors in control and CMS-exposed mice. AAV2-HCN2-eGFP or AAV2-eGFP was microinjected into the VTA bilaterally in C57BL/6J mice. After one week of recovery, mice were subjected to CMS or normal handling (non-stressed control) for 5 weeks, followed by behavioral testing.

Two-way ANOVA indicates that CMS and HCN2 overexpression had significant effects on body weight (CMS: *F*~1,36~ = 11.1, p=0.002; HCN2: *F*~1,36~ = 10.6, p=0.003; CMS x HCN2 interaction: *F*~1,36~ = 4.7, p=0.038; [Figure 8B](#fig8){ref-type="fig"}). CMS-exposed mice showed a significant decrease in body weight compared with control mice in the AAV2-eGFP injection group (p\<0.001), and this decrease was prevented by HCN2 overexpression (p\<0.001; [Figure 8B](#fig8){ref-type="fig"}). Two-way ANOVA indicates that the total distance travelled in the OFT was not significantly different (CMS: *F*~1,36~ = 0.01, p=0.977; HCN2: *F*~1,36~ = 0.9, p=0.85; CMS x HCN2 interaction: *F*~1,36~ = 0.4, p=0.549; [Figure 8C](#fig8){ref-type="fig"}). However, CMS and HCN2 overexpression had significant effects on the time spent in the center square of the open field (CMS: *F*~1,36~ = 7.1, p=0.012; HCN2: *F*~1,36~ = 5.6, p=0.023, CMS x HCN2 interaction, *F*~1,36~ = 4.6, p=0.040; [Figure 8C](#fig8){ref-type="fig"}). Tukey's *post hoc* tests indicate that CMS significantly decreased the time spent in the center square in AAV2-eGFP-expressing mice compared with the stress-naïve group (p=0.002), but this decrease was prevented by HCN2 overexpression (p=0.004; [Figure 8C](#fig8){ref-type="fig"}). In the SPT, CMS and HCN2 overexpression had significant effects on sucrose preference (CMS: *F*~1,36~ = 14.0, p\<0.001; HCN2: *F*~1,36~ = 21.7, p\<0.001, CMS x HCN2 interaction: *F*~1,36~ = 10.5, p=0.003; [Figure 8D](#fig8){ref-type="fig"}). Sucrose preference was significantly decreased in CMS mice compared to control mice (p\<0.001) in the AAV2-eGFP injection group, but this decrease was prevented by HCN2 overexpression (p\<0.001; [Figure 8D](#fig8){ref-type="fig"}). In the EPM test, neither CMS nor HCN2 overexpression had significant main effects on open arm entries (CMS: *F*~1,36~ = 0.6, p=0.441; HCN2: *F*~1,36~ = 0.3, p=0.604; CMS x HCN2 interaction: *F*~1,36~ = 2.6, p=0.115; [Figure 8E](#fig8){ref-type="fig"}) nor the time spent in the open arms (CMS: *F*~1,36~ = 0.7, p=0.413; HCN2: *F*~1,36~ = 1.4, p=0.239; CMS x HCN2 interaction: *F*~1,36~ = 2.1, p=0.159; [Figure 8E](#fig8){ref-type="fig"}). Planned comparison indicates that although CMS significantly decreased open arm time in AAV2-GFP-expressing mice (p=0.023), HCN overexpression did not significantly prevent the CMS-induced reduction in open arm time (p=0.057). In the NSF test, CMS and HCN2 overexpression had significant effects on the latency to feed in the novel environment (CMS: *F*~1,36~ = 8.5, p=0.006; HCN2: *F*~1,36~ = 8.3, p=0.007; CMS x HCN2 interaction: *F*~1,36~ = 4.4, p=0.044; [Figure 8F](#fig8){ref-type="fig"}). Tukey's *post hoc* tests indicated that in the AAV2-eGFP injection group, CMS significantly increased the latency to feed (p=0.002). HCN2 overexpression prevented the increased latency to feed in CMS-exposed mice (p=0.001), but did not affect the latency to feed in control mice (p=0.573; [Figure 8F](#fig8){ref-type="fig"}). In contrast, neither CMS nor HCN2 overexpression affected the latency to feed in the home cage (CMS: *F*~1,36~ = 0.6, p=0.463; HCN2: *F*~1,36~ = 2.4, p=0.132; CMS x HCN2 interaction: *F*~1,36~ = 0.1, p=0.748; [Figure 8F](#fig8){ref-type="fig"}), suggesting that changes in the latency to feed in the novel environment cannot be explained by changes in appetite. In the FST, CMS and HCN2 overexpression significantly affected the immobility time (CMS: *F*~1,36~ = 20.6, p\<0.001; HCN2: *F*~1,36~ = 22.1, p\<0.001; CMS x CHN2 interaction: *F*~1,36~ = 11.4, p=0.002; [Figure 8G](#fig8){ref-type="fig"}). Tukey's *post hoc* tests indicated that in the AAV2-eGFP injection group, CMS significantly increased the immobility time (p\<0.001). HCN2 overexpression prevented the CMS-induced increase in immobility time (p\<0.001), but it did not affect immobility time in control mice (p=0.350; [Figure 8G](#fig8){ref-type="fig"}). These results indicate that HCN2 overexpression in the VTA prior to CMS exposure prevents the development of depressive-like behaviors.

Discussion {#s3}
==========

VTA dopamine neuron AP firing is altered in chronic stress models of depression ([@bib17]; [@bib19]; [@bib70]; [@bib88]), and modulating this firing can reverse or enhance the development and/or expression of depression-like behavior ([@bib20]; [@bib29]; [@bib88]). Here, we have identified a putative mechanism linking CMS to decreased VTA dopamine neuron firing and the resulting behavioral deficits. We show in mice that following CMS, depressive- and anxiety-like behaviors and decreased VTA dopamine neuron firing are associated with reduced I~h~ current and a hyperpolarizing shift in I~h~ current in VTA dopamine neurons. Importantly, this decrease in I~h~ current is behaviorally relevant, as shRNA knockdown of HCN2 in the VTA was sufficient to recapitulate depressive- and anxiety-like behavior, while VTA HCN2 overexpression prevented the CMS-induced development of depressive-like behavior. Thus, the downregulation of HCN2 channels in VTA dopamine neurons may be a primary contributor to the CMS-induced development of depressive- and anxiety-like behaviors.

CMS or other homotypic chronic stressors typically cause decreases in population activity, tonic and burst firing in VTA dopamine neurons ([@bib19]; [@bib68]; [@bib70]; [@bib88]). We showed that the population activity, as well as the frequency of tonic and burst firing in VTA dopamine neurons were decreased in CMS-exposed mice. Importantly, our in vivo recordings targeted the lateral PBP, which is a more lateral subdivision of the VTA where dopamine neurons predominantly project to the lateral shell of the NAc ([@bib50]; [@bib51]) and play a primary role in reward and motivated behavior ([@bib51]; [@bib52]). Interestingly, CMS leads to decreased population activity in medial and central regions of the VTA but does not significantly alter population activity in the lateral VTA in the rat ([@bib70]). Further, no change in firing rate or burst firing was found in any VTA region ([@bib70]), consistent with their previous work ([@bib19]; [@bib68]). In contrast, our study and a previous study ([@bib88]) found significant reductions in firing rate and burst firing following CMS, and we found decreased population activity in lateral VTA dopamine neurons. We suspect this discrepancy is due to differences in CMS paradigms and animal species, as the former studies applied 3--4 stressors/week over 4 weeks in rats ([@bib19]; [@bib70]), whereas our study applied 14 stressors/week over 5 weeks in mice, and [@bib88] applied 14 stressors/week over 8--12 weeks in mice.

Both CMS and CSDS are commonly-used rodent models of depression ([@bib32]; [@bib47]; [@bib48]; [@bib95]). Interestingly, CMS and CSDS produce distinct, even opposite effects on VTA dopamine neuron firing ([@bib20]; [@bib37]; [@bib88]). CSDS, in contrast to CMS, increases tonic and burst firing in mice susceptible to CSDS, but not in resilient mice ([@bib3]; [@bib17]; [@bib20]; [@bib29]; [@bib47]). Additionally, optogenetic phasic stimulation of NAc-projecting VTA neurons induced susceptibility to subthreshold social defeat stress, whereas optogenetic inhibition of the VTA--NAc projection induced resilience to CSDS ([@bib20]). However, optogenetic phasic stimulation of VTA dopamine neurons reversed the CMS-induced decrease in sucrose preference and increase in immobility in the tail suspension test (TST) ([@bib88]). Interestingly, in non-stressed mice, optogenetic inhibition of VTA dopamine neurons was sufficient to reduce sucrose preference and increase immobility in the TST ([@bib88]). Thus, these two models do not produce unitary effects on dopamine neuronal activity, and optogenetic manipulations of dopamine neuronal activity produce divergent behavioral changes, depending on the animal model used. Perhaps manipulations that *normalize* disruptions in AP firing induced by CMS or CSDS can produce antidepressant-like or resilient phenotypes.

In VTA dopamine neurons, I~h~ current generates pacemaker activity together with other voltage-dependent ion channels. Pharmacological manipulations that increase I~h~ current in VTA dopamine neurons lead to increased AP firing frequency ([@bib29]; [@bib92]), whereas the I~h~ blocker ZD7288 reduces spontaneous AP firing in VTA dopamine neurons ([@bib66]; [@bib73]). We therefore investigated whether CMS altered I~h~ current in VTA dopamine neurons, as this may contribute to the CMS-induced reduction in AP firing. VTA dopamine neurons are heterogeneous in their afferent and efferent connectivity ([@bib13]; [@bib69]) and electrophysiological properties ([@bib30]; [@bib50]; [@bib51]). Dopamine neurons in the lateral VTA typically fire with low-frequency (\<10 Hz), project to the NAc lateral shell, and exhibit a large I~h~ current, and both rewarding and aversive stimuli modify synapses onto these dopamine neurons ([@bib51]). CSDS increases I~h~ current in NAc-projecting VTA neurons but not in mPFC-projecting VTA neurons in susceptible mice ([@bib17]; [@bib29]). Interestingly, the amplitude of I~h~ current in NAc-projecting VTA neurons is further increased in resilient mice, but normal AP firing in these mice is made possible via homeostatic upregulation of voltage-gated K^+^ currents ([@bib29]; [@bib47]). However, whether CMS affects I~h~ current in these neurons had not been previously investigated.

Using Retrobead injections into the NAc lateral shell, we found that I~h~ amplitude and I~h~ current density were significantly decreased in NAc-projecting VTA dopamine neurons in CMS-exposed mice compared with that of control mice. CMS also led to a significant hyperpolarizing shift (\~−5 mV) of V~1/2~, which can reduce I~h~ activation to hyperpolarizing stimuli. The mechanisms for this hyperpolarizing shift remain to be investigated. Additionally, we found that AP firing in VTA dopamine neurons ex vivo was significantly decreased in CMS-exposed mice. Unlike in vivo, the burst firing activity of VTA dopamine neurons is lacking ex vivo, likely due to the severing of synaptic inputs during slice cutting ([@bib66]). Nevertheless, we isolated the cell-autonomous effect of I~h~ current on AP firing by performing cell-attached recordings in the presence of the glutamate receptor and GABA~A~ receptor antagonists. We found that AP firing was decreased in CMS slices, and that the I~h~ blocker ZD7288 produced a greater decrease in the firing rate in control slices than in CMS slices. Together, these studies indicate that CMS induced a decrease in I~h~ current in VTA dopamine neurons, likely leading to the decrease in AP firing in vivo following CMS.

HCN channels contribute to resting membrane potential and conductance in neuronal cell bodies ([@bib5]), dendrites ([@bib87]), and presynaptic terminals ([@bib38]). Consistent with this, we found that knockdown of HCN2 led to a significant decrease in resting membrane conductance, as derived from the instantaneous inward currents present immediately after hyperpolarizing voltage steps from a holding potential of −60 mV. Additionally, CMS led to a non-significant trend towards reduced resting conductance. These results together suggest that HCN2 channels modestly contribute to overall resting membrane conductance.

HCN1, HCN2 and the auxiliary subunit TRIP8b have previously been shown to regulate behavioral despair. *Hcn1* or *Trip8b* knockout leads to reduced immobility in the tail suspension test and forced swim test, and *Hcn2^ap/ap^* mice show reduced immobility in the tail-suspension test, but these mice exhibit deficits in motor coordination and locomotion and cannot swim ([@bib56]). However, anxiety-like behavior is not altered in these three knockout mice in the elevated plus maze, dark/light box and marble burying tests ([@bib56]). Additionally, CMS induces an increase in HCN1 currents in the dorsal hippocampus, and shRNA knockdown of HCN1 in the dorsal hippocampus produced anxiolytic- and antidepressant-like behaviors ([@bib43], [@bib42]). Hippocampal CA1 pyramidal neurons usually do not fire spontaneous APs at resting membrane potential, and HCN1 channels at CA1 neuron distal dendrites limit neuronal excitability by reducing the integration of synaptic inputs ([@bib61], [@bib62]; [@bib87]), in part through interactions with M-type K^+^ channels ([@bib31]). Interestingly, depolarizing current injections elicited significantly more action potentials following HCN1 knockdown, knockout, and I~h~ blockade in hippocampal neurons ([@bib42]; [@bib56]). In contrast, consistent with previous studies ([@bib66]; [@bib73]), we found that an HCN blocker or knockdown of HCN2 decreases AP firing in VTA dopamine neurons. Thus, it seems that the functional role of HCN channels depends on several factors, including the cellular location of HCN expression (e.g. distal dendrite vs. cell soma), the HCN isoform, the cell type in which HCN channels are expressed, and likely other factors. In VTA dopamine neurons, our results support a 'pro-excitability' role for HCN2, likely by generating a pacemaker current to support repetitive AP firing. It is possible that the differing neurophysiological functions of HCN channels in the dorsal hippocampus compared with VTA dopamine neurons may account for the opposing behavioral effects of HCN inhibition or activation in these structures.

Overexpression of HCN2 in VTA dopamine neurons, or intra-VTA infusion of the I~h~ potentiator lamotrigine, produces the resilient phenotype in mice subjected to CSDS by activating a homeostatic mechanism leading to an upregulation of voltage-gated K^+^ channels and normalization of AP firing ([@bib29]). Interestingly, intra-VTA infusion of an I~h~ inhibitor can also promote the resilient phenotype following CSDS ([@bib17]). How might an I~h~ inhibitor lead to the same behavioral effect as I~h~ potentiation? Whereas the I~h~ inhibitor was applied acutely to CSDS-susceptible mice and presumably decreased abnormally elevated dopamine neuron firing ([@bib17]), lamotrigine was administered repeatedly for five days and HCN2 was allowed to overexpress for four days before behavioral assessments were carried out ([@bib29]). I~h~ potentiation led to an upregulation of K^+^ currents in each scenario, leading to a reduction in otherwise abnormally elevated dopamine neuron excitability. In our study, CMS- or shRNA-mediated suppression of I~h~ current leads to abnormally decreased dopamine neuron firing, and results in depressive- and anxiety-like behavior. Altogether, these findings support the notion that abnormal dopamine neuron firing is a unifying contributor to the development of depressive-like behavior.

Although shRNA-mediated HCN2 knockdown recapitulated the behavioral effects of CMS, it did not affect body weight. As body weight was measured 3 weeks after HCN2 knockdown, whereas the CMS-induced decrease in body weight was observed after 5 weeks of CMS, it is possible that body weight perturbations induced by HCN2 knockdown require additional time to manifest. Alternatively, HCN2 knockdown may not recapitulate all effects of CMS. Importantly, although the HCN2 knockdown was not cell type-specific, VTA dopamine neurons should be predominantly affected by the knockdown, as VTA GABA and glutamate neurons in mice exhibit little to no I~h~ current ([@bib22]; [@bib36]). Further, VTA dopamine neurons projecting to the mPFC, NAc medial shell, or basolateral amygdala exhibit minimal I~h~ current ([@bib4]; [@bib50]; [@bib51]). Thus, NAc lateral shell-projecting VTA dopamine neurons should be the predominant VTA population affected by the knockdown.

Additionally, overexpression of HCN2 in the VTA prevented the majority of CMS-induced behavioral deficits and produced antidepressant-like effects. In the CSDS model, HCN2 overexpression selectively in NAc-projecting VTA neurons, but not in mPFC-projecting VTA neurons, normalizes social interaction deficits ([@bib29]). Thus, it is likely that enhancing I~h~ current promotes the resilient phenotype in CSDS via effects on the VTA-NAc pathway. A limitation of our study is that although HCN2 overexpression is VTA-specific, it is not cell type- or projection-specific. As the VTA is heterogeneous with regard to cell type, connectivity, and behavioral function ([@bib69]), future studies employing more sophisticated viral tools for cell- and projection-specific overexpression of HCN2 will likely be necessary to parse out the contributions of individual VTA circuits to CMS-induced behavioral deficits. Nevertheless, a salient commonality between these studies is that I~h~ potentiation is capable of producing antidepressant-like phenotypes in both models, despite the fact that CSDS and CMS induced distinct neuroadaptations in VTA dopamine neuron activity and I~h~ current.

HCN channels have been implicated in a variety of brain disorders, including epilepsy ([@bib6]), Parkinson's disease ([@bib18]), neuropathic pain ([@bib23]), tinnitus ([@bib57]), and Neurofibromatosis type 1 ([@bib74]). Additionally, the rewarding effects of ethanol are believed to arise in part from activating HCN channels in VTA dopamine neurons ([@bib73]; [@bib84]). Consistent with this idea, overexpression of HCN2 in the VTA increases ethanol reward and consumption in rats ([@bib78]), perhaps through an increased ethanol-induced activation of I~h~ current and AP firing in dopamine neurons. Further, chronic ethanol exposure can reduce I~h~ current in VTA dopamine neurons ([@bib73]). Given that alcohol use disorder (AUD) and major depressive disorder (MDD) are frequently comorbid in humans ([@bib96]), and that AUD can prospectively predict future MDD ([@bib11]; [@bib14]), a speculative mechanistic explanation is that chronic alcohol use leads to downregulation of HCN2 in VTA dopamine neurons, which may directly contribute to the development of depressive behavior. Given the widespread distribution ([@bib72]) and functional diversity ([@bib81]) of HCN channels in the brain, it is likely that HCN channels play important roles in a wide variety of physiological and pathophysiological processes.

Clinical and animal studies suggest that VTA dopamine neurons and their major projection target, the NAc, play a critical role in the pathophysiology of depression. Depression and anxiety occur in 40--50% of patients with Parkinson\'s disease and these symptoms sometimes precede the appearance of motor dysfunction ([@bib16]; [@bib24]; [@bib85]). The dopamine agonist pramipexole produces antidepressant effects in patients who failed to respond to standard antidepressant treatments ([@bib28]). Different molecular changes in the VTA to NAc pathway confer vulnerability or resilience to chronic social defeat stress (CSDS) ([@bib7]; [@bib27]; [@bib47]), though relatively few studies have been conducted to study CMS-induced neuroadaptations in the mesolimbic dopamine system. The present study reveals that CMS is associated with a decrease in both AP firing and I~h~ current in VTA dopamine neurons that project to the NAc. Additionally, HCN2 knockdown in the VTA was sufficient to induce depressive- and anxiety-like behavior in non-stressed mice, whereas HCN2 overexpression prevented the CMS-induced development of depressive-like behavior. Thus, HCN2 channels in the VTA play a critical role in regulating depressive- and anxiety-like behavior in both unstressed and chronically stressed mice.

Materials and methods {#s4}
=====================

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\      Designation                       Source or reference                  Identifiers                                                              Additional information
  or resource                                                                                                                                                                  
  ---------------------------- --------------------------------- ------------------------------------ ------------------------------------------------------------------------ ---------------------------
  Strain, strain background\   male C57BL/6J mice                The Jackson Laboratory               Stock\#: 000664\                                                         
  (*Mus musculus*)                                                                                    RRID:[IMSR_JAX:000664](https://scicrunch.org/resolver/IMSR_JAX:000664)   

  Genetic reagent\             male heterozygous\                The Jackson Laboratory               Stock\#: 006660\                                                         maintained on the\
  (*Mus musculus*)             *Slc6a3^Cre+/−^* (DAT-Cre) mice                                        RRID:[IMSR_JAX:006660](https://scicrunch.org/resolver/IMSR_JAX:006660)   C57BL/6J background

  Genetic reagent\             male Ai9 reporter mice            The Jackson Laboratory               Stock\#: 007909\                                                         maintained on the\
  (*Mus musculus*)                                                                                    RRID:[IMSR_JAX:007909](https://scicrunch.org/resolver/IMSR_JAX:007909)   C57BL/6J background

  Strain, strain background\   AAV2.shRNA.U6.ShRLuc.\            shRNA provided by Dr. Han-gang Yu\                                                                            
  (*Adeno-associated virus*)   CMV.eGFP.SV40                     (PMID: 19236845), packed into\                                                                                
                                                                 AAV2 at Penn Vector Core                                                                                      

  Strain, strain background\   AAV2.scramble.U6.ShRLuc.\         Penn Vector Core                                                                                              
  (*Adeno-associated virus*)   CMV.eGFP.SV40                                                                                                                                   

  Strain, strain background\   AAV2.CMV.PI.HCN2.\                HCN2 plasmid packed into\                                                                                     HCN2 plasmid provided by\
  (*Adeno-associated virus*)   WPRE.eGFP.SV40                    AAV2 at Penn Vector Core                                                                                      Dr. Dane Chetkovich at\
                                                                                                                                                                               Northwestern University

  Strain, strain background\   AAV2.CMV.PI.eGFP.WPRE.bGH         Penn Vector Core                                                                                              
  (*Adeno-associated virus*)                                                                                                                                                   

  Antibody                     Mouse anti-TH                     Santa Cruz Biotechnology             SC-136100, Lot: G1309,\                                                  monoclonal, 1:300
                                                                                                      RRID:[AB_2287193](https://scicrunch.org/resolver/AB_2287193)             

  Antibody                     Rabbit anti-TH                    Santa Cruz Biotechnology             SC-14007, Lot: C2707,\                                                   polyclonal, 1:300
                                                                                                      RRID:[AB_671397](https://scicrunch.org/resolver/AB_671397)               

  Antibody                     Rabbit anti-NeuN                  Millipore                            ABN78, Lot: 2702139,\                                                    polyclonal, 1:400
                                                                                                      RRID:[AB_10807945](https://scicrunch.org/resolver/AB_10807945)           

  Antibody                     anti-mouse IgG\                   Cell Signaling                       Stock \#4409,\                                                           Goat anti-mouse, 1:300
                               Alexa Fluor 555                                                        RRID:[AB_1904022](https://scicrunch.org/resolver/AB_1904022)             

  Antibody                     anti-rabbit IgG\                  Invitrogen                           A21245, Lot: 1445259,\                                                   Goat anti-rabbit, 1:100
                               Alexa Fluor 647                                                        RRID:[AB_141775](https://scicrunch.org/resolver/AB_141775)               

  Antibody                     anti-mouse IgG\                   Cell Signaling                       Stock \#4408,\                                                           Goat anti-mouse, 1:300
                               Alexa Fluor 488                                                        RRID:[AB_10694704](https://scicrunch.org/resolver/AB_10694704)           

  Antibody                     anti-rabbit IgG\                  Cell Signaling                       Stock \#4412,\                                                           Goat anti-rabbit, 1:500
                               Alexa Fluor 488                                                        RRID:[AB_1904025](https://scicrunch.org/resolver/AB_1904025)             

  Other                        neurobiotin tracer                Vector Laboratories                  SP-1120,\                                                                1.5%
                                                                                                      RRID:[AB_2336606](https://scicrunch.org/resolver/AB_2336606)             

  Other                        Texas Red avidin D                Vector Laboratories                  A-2006,\                                                                 1:100
                                                                                                      RRID:[AB_2336751](https://scicrunch.org/resolver/AB_2336751)             

  Software (Sigmaplot 11.2)                                                                           RRID:[SCR_003210](https://scicrunch.org/resolver/SCR_003210)             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

Animal maintenance and use were in accordance with protocols approved by the Institutional Animal Care and Use Committee of the Medical College of Wisconsin. Mice were given *ad libitum* access to food and water, and housed four to five per cage in a temperature (23 ± 1°C) and humidity-controlled room (40--60%) with a 12 hr light-dark cycle. All experiments were performed on adult male mice (8--10 week-old at the beginning of the experiments). C57BL/6J, heterozygous *Slc6a3^Cre+/−^* mice (simplified as DAT-Cre; Jax stock\#: 006660), and Ai9 Cre reporter mice (strain code: B6.Cg-Gt(ROSA)26Sor*^tm9(CAG-tdTomato)Hze^*/J; Jax stock\#: 007909,) were obtained from the Jackson Laboratory (Bar Harbor, Maine). All of the mouse lines were maintained on the same C57BL/6J background. By crossing DAT-Cre mice with Ai9 Cre reporter mice, we have generated DAT-tdTomato reporter mice in which tdTomato is selectively expressed in dopamine neurons, which allowed unambiguous identification of tdTomato-fluorescent dopamine neurons during ex vivo slice electrophysiology.

Animal surgery and microinjection of retrobeads or AAVs {#s4-2}
-------------------------------------------------------

Mice were anesthetized with ketamine (90 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) and placed in a stereotaxic device (David Kopf Instruments, Tujunga, CA). For retrograde tracing, green Retrobeads (0.1 µl; LumaFluor Inc., Naples, FL) were injected bilaterally in the lateral shell of the NAc of DAT-tdTomato reporter mice (coordinates from bregma: AP 1.45 mm; ML ±1.75 mm; DV −4.4 mm). The following AAVs (0.2 µl) were injected into the VTA bilaterally (coordinates from bregma: AP −3.1 mm; ML ±1.0 mm; DV −4.8 mm at a 7° angle) ([@bib75]). HCN2-shRNA and scramble-shRNA constructs were provided by Dr. Han-gang Yu at West Virginia University ([@bib97]) and were packaged into AAV2 with an eGFP reporter (AAV2.shRNA.U6.ShRLuc.CMV.eGFP.SV40) at Penn Vector Core, University of Pennsylvania (Philadelphia, PA). The HCN2 plasmid was provided by Dr. Dane Chetkovich at Northwestern University and was packaged into AAV2 at Penn Vector Core (AAV2.CMV.PI.HCN2.WPRE.eGFP.SV40, referred as 'AAV2-HCN-eGFP'). AAV2.CMV.PI.eGFP.WPRE.bGH (referred as 'AAV2-eGFP') serves as a control. The injections of Retrobeads and AAVs were through a Nanoject III Programmable Nanoliter Injector (Drummond Scientific Company, Broomall, PA). The injection rate was 60 nl/min, and the injectors were kept in place for an additional 5 min to ensure adequate diffusion from the injector tip. After the surgery, animals received subcutaneous injections of analgesic (buprenorphine-SR, 1 mg/kg). Mice were allowed to recover for 1 week before CMS experiments or 3 weeks before slice electrophysiology or immunofluorescence staining unless stated otherwise.

Chronic unpredictable mild stress (CMS) paradigm {#s4-3}
------------------------------------------------

Equal numbers of male C57BL/6J mice and DAT-tdTomato reporter mice (on C57BL/6J background) were subjected to CMS for a total of 5 weeks based on published studies ([@bib46]; [@bib94]). The stressors included restraint (1 hr in a soft, flexible plastic cone, DecapiCone, Braintree Scientific, Inc.), inversion of day/night light cycle, cold (in a cold room at 4°C for 1 hr), 45° tilted cage (overnight), cage rotation (20 min), rat bedding (odor, 3 hr), wet bedding (250 ml water added into cage, overnight), no bedding (overnight), low intensity stroboscopic illumination (10 Hz, overnight), food and water deprivation (overnight), and overcrowding (overnight). Two stressors were administered per day. The timeline of the stressor exposure has been described in detail in our recent studies ([@bib98], [@bib99]) and also in [Table 1](#table1){ref-type="table"}. Non-stressed controls were handled only for cage changes and behavioral tests.

10.7554/eLife.32420.020

###### Experimental schedule for the chronic mild stress (CMS) procedure in mice

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Week    Monday                       Tuesday                      Wednesday          Thursday                     Friday                       Saturday                     Sunday
  ------- ---------------------------- ---------------------------- ------------------ ---------------------------- ---------------------------- ---------------------------- ------------------
  **1**   Cold\                        Restraint\                   Light inversion\   Cage rotation\               Cold\                        Restraint\                   Light inversion\
          Wet bedding                  No bedding                   Cage tilt          Strobe                       Food and water deprivation   Overcrowding                 Wet bedding

  **2**   Cold\                        Cage rotation\               Restraint\         Rat bedding Strobe           Light inversion\             Cage rotation\               Cold\
          Cage tilt                    Food and water deprivation   Wet bedding                                     No bedding                   Food and water deprivation   Wet bedding

  **3**   Rat bedding\                 Restraint\                   Cage rotation\     Light inversion\             Cold\                        Cage tilt\                   Light inversion\
          Strobe                       Light inversion              No bedding         Food and water deprivation   Wet bedding                  Strobe                       Overcrowding

  **4**   Cold\                        Restraint\                   Cage rotation\     Rat bedding\                 Cold\                        Restraint\                   Cage rotation\
          No bedding                   Food and water deprivation   Strobe             Light inversion              Cage tilt                    Wet bedding                  No bedding

  **5**   Cold\                        Cage rotation\               Light inversion\   Cold\                        Cage rotation\               Light inversion\             Restraint\
          Food and water deprivation   Strobe                       Wet bedding        Cage tilt                    No bedding                   Overcrowding                 Cage tilt
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Behavior {#s4-4}
--------

Behavioral tests have been described in detail in our recent studies ([@bib98], [@bib99]). Behavioral testing was carried out by experimenters blind to genotype, group, and/or treatment history, and less stressful behavioral tests were typically tested before more stressful behavioral tests. Behavioral tests were conducted in the order listed below, with only one behavioral test conducted per day.

### Open field test (OFT) {#s4-4-1}

Mice were placed individually in one corner of an open field (50 cm length x 45 cm wide x 30 cm deep box) and allowed to freely explore the arena during a 20 min test session. Locomotor activity was recorded using an automated video-tracking system (Mobile Datum, Shanghai, China). Total distance traveled and time spent in the center of the box during the first 5 min was calculated. Center time is defined as the amount of time that was spent in the central 25 cm x 22.5 cm area of the open field.

### Sucrose preference test (SPT) {#s4-4-2}

Mice were individually housed and trained to drink from two drinking bottles for 48 hr. One bottle contained 1% sucrose (in tap water) and the other contained tap water. The SPT was carried out after the OFT. During the SPT, mice were deprived of food and water for 8 hr, and the consumption of sucrose solution and water over the next 16 hr was measured. Sucrose preference (%) was calculated as sucrose solution consumed divided by the total amount of solution consumed.

### Elevated plus maze (EPM) {#s4-4-3}

The EPM apparatus (Stoelting, Wood Dale, IL) consists of two open arms (35 × 5 cm) across from each other and perpendicular to two closed arms (35 × 5 × 15 cm) that are connected by a center platform (5 × 5 cm). The apparatus is elevated 40 cm above the floor. Mice were placed in the center platform facing a closed arm and allowed to freely explore the maze for 5 min. The location of the mice was tracked with the automated video-tracking system. The percent of entries into open arms and time spent in open arms were analyzed.

### Novelty-suppressed feeding (NSF) {#s4-4-4}

The NSF test was carried out similar to a published protocol ([@bib80]). Mice were food deprived for 24 hr before being placed in a novel environment (a plastic box 45 cm long x 35 cm wide x 20 cm deep) where five food pellets (regular chow) were placed on a piece of white filter paper (11 cm in diameter) in the center of the box. A mouse was placed in one corner of the box and the latency to feed was measured. Feeding was defined as biting the food with the use of forepaws, but not simply sniffing or touching the food. Immediately after the test, the animal was transferred to the home cage, and the latency to feed in the home cage was measured to serve as a control.

### Forced swim test (FST) {#s4-4-5}

Mice were placed individually into glass cylinders (13 cm diameter, 25 cm tall) filled to a depth of 18 cm with water (30 ± 1°C). The mice were placed in the cylinders for 6 min. The time spent immobile during the last 4 min was scored. Immobility was defined as the cessation of all movements (e.g., climbing, swimming) except those necessary for the mouse to keep its head above water (i.e., floating).

In vivo electrophysiology {#s4-5}
-------------------------

One day after the last behavioral test, CMS and time-matched control mice were anesthetized with urethane (1.5 mg/kg, i.p.) and were positioned in a stereotaxic frame (David Kopf Instruments). Their body temperature was maintained at 37°C using a heating pad. Craniotomies were performed to allow single-unit recordings of VTA dopamine neurons. The areas for electrode insertion were moisturized with saline. Single unit recording electrodes were pulled from micropipettes (O.D., 1 mm, I.D., 0.5 mm) to a resistance of 10--15 MΩ when filled with 2 M NaCl containing 1.5% neurobiotin. The electrode was lowered into the VTA (coordinates from bregma: AP −2.9 to −3.3 mm, ML 0.6 to 1.1 mm, DV −3.9 to −4.5 mm) through a micromanipulator, and a reference electrode was placed in the subcutaneous tissue. These coordinates primarily correspond to the lateral parabrachial pigmented nucleus (PBP) of the VTA. Single-unit activity was acquired with a Multiclamp 700B amplifier and a DigiData 1440A digitizer and was analyzed by pClamp 10.3 (Molecular Devices). Signals were sampled at 10 kHz, and the bandpass filter was set between 0.3 and 5 kHz ([@bib10]; [@bib13]; [@bib20]). Dopamine neurons were identified by a broad triphasic extracellular action potential of a width greater than 2 ms and a relatively slow firing rate (\<10 Hz) ([@bib89]). Burst firing was defined as beginning when two action potentials have an inter-spike interval of \<80 ms and ending when two action potentials have an inter-spike interval of \>160 ms ([@bib9]; [@bib21]; [@bib33]; [@bib83]). These criteria provide reliable identification of dopamine neurons in vivo, as determined by juxtacellular labeling and colocalization with tyrosine hydroxylase (TH) ([@bib90]; [@bib89]). Nevertheless, we did juxtacellular labeling with neurobiotin to verify the identity of dopamine neurons. Briefly, following the last electrophysiological recording in each mouse, positive current pulses (7 s on/off cycles) were applied through the recording electrode to the neuron for 4--10 min. The neurobitotin was allowed to transport within the neuron for another 1--2 hr before the animals were prepared for immunofluorescence staining ([@bib10]; [@bib76]). To avoid potential effects of the labeling procedure on neuron firing, no additional neurons were recorded following neurobiotin electroporation.

Slice preparation and electrophysiology {#s4-6}
---------------------------------------

One day after the last behavioral test, CMS and time-matched control DAT-tdTomato reporter mice were anaesthetized by isoflurane inhalation and decapitated. The brain was trimmed and embedded in 3% low-melting-point agarose, and horizontal midbrain slices (200 μm thick) were cut using a vibrating slicer (Leica VT1200s, Nussloch, Germany), as described in our recent studies ([@bib58]; [@bib86]). Slices were prepared in a choline-based solution containing (in mM): 110 choline chloride, 2.5 KCl, 1.25 NaH~2~PO~4~, 0.5 CaCl~2~, 7 MgSO~4~, 26 NaHCO~3~, 25 glucose, 11.6 sodium ascorbate, and 3.1 sodium pyruvate at room temperature. The VTA slices were cut in the midline to produce two individual slices from each section. The slices were incubated for 30 min in sucrose-based solution containing (in mM): 78 NaCl, 68 sucrose, 26 NaHCO~3~, 2.5 KCl, 1.25 NaH~2~PO~4~, 2 CaCl~2~, 2 MgCl~2~ and 25 glucose. Then, the slices were allowed to recover for at least 30 min in the artificial cerebrospinal fluid (ACSF) containing (in mM): 119 NaCl, 2.5 KCl, 2.5 CaCl~2~, 1 MgCl~2~, 1.25 NaH~2~PO~4~, 26 NaHCO~3~, and 10 glucose. All solutions were saturated with 95% O~2~ and 5% CO~2~.

Whole-cell and cell-attached patch-clamp recordings were made as described in our previous study ([@bib100]). Recordings were made using patch-clamp amplifiers (Multiclamp 700B) under infrared differential interference contrast (DIC) microscopy. Data acquisition and analysis were performed using DigiData 1440A and 1550B digitizers and the analysis software pClamp 10.3 (Molecular Devices). Signals were filtered at 2 kHz and sampled at 10 kHz. I~h~ current was measured by inducing 1.5 s hyperpolarizing steps from −60 mV to −130 mV with −10 mV steps. Junction potentials between the patch pipette and bath ACSF were nullified prior to obtaining a seal. For the generation of I~h~ activation curves, 1.5 s hyperpolarizing steps to various potentials (−60 to −130 mV) were applied from a holding potential of −60 mV and tail currents were measured at −130 mV. Tetraethylammonium chloride (TEA-Cl, 10 mM) was included in the ACSF to block non-inactivating voltage-dependent K^+^ conductance and osmolality was maintained by equimolar reduction of NaCl from the ACSF. Tail current amplitudes at −130 mV, after subtraction of the current following no hyperpolarizing step, were plotted as a function of test potentials. The I~h~ activation curve was fitted with a Boltzmann function *I* = *I*~max~/exp\[(*V*~m~ -- *V*~1/2~)/s\], where *I*~max~ is the maximal tail current amplitude, *V* is the test potential, *V*~1/2~ is the half-activation potential, and *s* is the slope factor. Resting membrane conductance was approximated from voltage clamp recordings in a manner similar to ([@bib44]). Hyperpolarizing voltage steps from a resting holding potential of −60 mV to −130 mV in 10 mV steps generated instantaneous inward currents (I~ins~). I~ins~ was plotted against the hyperpolarizing voltage steps. The slope of these I-V curves provides an approximation of the resting membrane conductance (G~resting~). Membrane capacitance was measured by Clampex software (Molecular Devices) using small amplitude hyperpolarizing and depolarizing steps (±5 mV). Firing rate was recorded in the cell-attached configuration in the presence of CNQX (10 µM), D-AP5 (20 µM) and picrotoxin (50 µM) to block excitatory and inhibitory synaptic transmission. Glass pipettes (3--5 MΩ) were filled with an internal solution containing (in mM): 140 K-gluconate, 10 KCl, 10 HEPES, 0.2 EGTA, 2 MgCl~2~, 4 Mg-ATP, 0.3 Na~2~GTP (pH 7.2 with KOH). Series resistance (10--20 MΩ) was monitored throughout all recordings, and data were discarded if the resistance changed by more than 20%. All recordings were performed at 32 ± 1°C by using an automatic temperature controller (Warner Instruments, Inc.).

Immunofluorescence staining {#s4-7}
---------------------------

Mice were anaesthetized by ketamine (90 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) and transcardially perfused with 0.1 M sodium phosphate buffered saline (PBS) followed by 4% paraformaldehyde in 4% sucrose-PBS (pH 7.4). After perfusion, the brain was removed and post-fixed in the same fixative for 4 hr at 4°C, and was then dehydrated in increasing concentrations of sucrose (20% and 30%) in 0.1 M PBS at 4°C and frozen on dry ice. Coronal VTA sections (20 µm) were cut with a Leica cryostat. VTA sections were incubated with antibodies against tyrosine hydroxylase (TH, mouse, 1:300, Santa Cruz Biotechnology) and/or NeuN (rabbit, 1:400; Millipore) at 4°C for 48 hr. VTA sections were then incubated with anti-mouse IgG Alexa Fluor 555-conjugated (goat, 1:300; Cell Signaling) and anti-rabbit IgG Alexa Fluor 647-conjugated (goat, 1:100; Invitrogen) or anti-mouse IgG Alexa Fluor 488-conjugated (goat, 1:300; Cell Signaling) secondary antibodies for 4 hr at room temperature in the dark. To reveal labeled cells using the juxtacellular method, VTA sections were first incubated with Texas Red avidin D (1:100; Vector Laboratories) to retrieve the labeled cell bodies. Then, the selected tissue sections were incubated with anti-TH (rabbit, 1:300; Santa Cruz Biotechnology; 48 hr) and anti-rabbit IgG Alexa Fluor 488-conjugated (goat, 1:500; Cell Signaling; 4 hr). Confocal imaging was performed using a Nikon TE2000-U inverted microscope equipped with the C1 Plus confocal system.

Chemicals {#s4-8}
---------

Picrotoxin, TTX and all other common chemicals were obtained from Sigma-Aldrich (St. Louis, MO). 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX), D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5) and ZD7288 were obtained from Tocris Bioscience (Ellisville, MO).

Data analysis and statistics {#s4-9}
----------------------------

All results are presented as the mean ±SEM. Results were analyzed with either Student's *t*-test, or two-way ANOVA followed by Tukey's *post hoc* analysis using Sigmaplot 11.2. Results were considered to be significant at p\<0.05.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"HCN2 Channels in the Ventral Tegmental Area Regulate Behavioral Responses to Chronic Stress\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Olivier Manzoni as the Reviewing Editor and Gary Westbrook as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: John T Williams (Reviewer \#2); Miriam Melis (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. We hope you will be able to submit the revised version within two months.

Summary:

Zhong et al. investigated the synaptic and molecular mechanisms underlying chronic mild stress (CMS)-induced reduction in Ventral Tegmental Area (VTA) dopamine (DA) neuron firing.

The authors used a combination of behavior, electrophysiology, and RNA knock-down/overexpression to investigate changes in overexpressed hyperpolarization -- activated cyclic nucleotide -- gated channel (HCN) currents after CMS, and the effect of manipulating HCN2 channels on behavior. The data first reveal that CMS causes anxiety- or depressive-like behavior, which is associated with reduced DA neuron activity in the VTA. Second, the results show that CMS reduces synaptic excitation of VTA DA neurons and HCN current. Finally, knock-down of HCN2 in the VTA was sufficient to induce depressive-like behavior in mice and over-expression of HCN2 in the VTA was sufficient to prevent depressive-like behavior in response to CMS.

Essential revisions:

1\) In their current state, the experiments studying synaptic parameters (i.e. minis, AMPA/NMDA ratio...) are: (1) per se not sufficient to provide mechanistic insights (2) rather confusing (see reviewers\' comments) (3) not sufficiently discussed. Thus, we advise that you remove this data set (and the corresponding discussion) from your revision. Alternatively, although it is not the reviewer\'s preferred option, the authors may choose performing all additional experiments suggested by the reviewers in their detailed reviews.

Also, for the sake of clarity, the Results section measuring the sag of membrane potential are really not necessary and should be removed.

2\) The VTA contains a heterogeneous population of DA neurons with respect to their projection targets and HCN channel expression. Specifically, neurons that project to the nucleus accumbens exhibit large HCN currents, whereas those that project to the prefrontal cortex do not.

It is imperative that the authors analyze (Results section) and interpret (Discussion section) their results in light of the different target populations and different cell types that were identified in the VTA. Notably, the paper by Friedman et al., 2014 where Ih and VTA neuronal excitability were studied in another stress paradigm and the article by Moreines et al., (2017) where reduced activity was observed in a subpopulation of VTA DA cells in a CMS model, must be discussed. Additionally, because of the \"laterality\" issue raised by Moreines et al., the authors are requested to document and discuss the location of the recorded DA cells (both ex vivo and in vivo).

3\) The revised version must include the following technical details:

-The resting conductance of the neurons must be provided in a table. The conductance of the cells illustrated in [Figure 4](#fig4){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"} are very different.

-The capacitance of the dopamine cells (50 pS) is about twice that which is often reported. How was the capacitance of the cells measured? What were the setting for the acquisition and filtering frequencies?

-In the figure legends, the statements of the number of n per group are not clear. For example, in [Figure 2E](#fig2){ref-type="fig"}, it states \"n=10-13 neurons from 4-5 mice\". Does this mean 4-5 mice per group (control vs CMS), or combined between both groups?

-The authors state that the C57BL/6 mice and the DAT-tdTomato mice did not show significant differences in their behavioral tests, so the results were pooled. The authors should show supplementary data to demonstrate this claim.

Reviewer \#1:

In this paper, Zhong et al. investigate how HCN2 channels in the Ventral Tegmental Area (VTA) regulate depressive-like behavior in response to chronic mild stress (CMS). The authors use a combination of behavior, electrophysiology, and RNA knock-down/overexpression to investigate changes in HCN current after CMS, and the effect of manipulating HCN channels on animals\' behavior. The authors present a number of important findings. First, they report that CMS causes anxiety- or depressive-like behavior, which is associated with reduced DA neuron activity in the VTA. Then, they report that CMS also causes reduced synaptic excitation of VTA DA neurons, as well as reduced HCN current. They went on to preform behavioral experiments to demonstrate that knock-down of HCN2 in the VTA is sufficient to induce depressive-like behavior in mice and that over-expression of HCN2 in the VTA is sufficient to prevent depressive-like behavior in response to CMS. This is an interesting paper with several important findings, but there are several unclear parts at this point

One unclear part with the study is a lack of mechanistic understanding of how modulation of HCN channels regulates DA neuron activity, in particular regarding the relationship between the observed changes in synaptic and intrinsic excitability. The authors show effects in minis and AMPA/NMDA ratio, but these findings are not followed up and are not put in the context of HCN channels. HCN channels can have effects on synaptic and intrinsic excitability (input resistance, resting membrane potential, etc.) but this is neither addressed or discussed

As a result, as it is currently presented, the synaptic excitation data is out of place and it is confusing how it is related, if at all, to the main finding regarding changes in HCN channels. There is only a very brief discussion mentioning that changes in synaptic input, as well as changes in HCN, may work together to underlie behavioral output.

The writing is also confusing: are the authors after the intrinsic and synaptic properties mediating the changes in the excitability of VTA neurons or are the after the role of H channels. The Intro was confusing in this regard too, as it does not prepare the reader as to what to expect

One other unclear point is whether the authors intend to focus on VTA DA neuron activity as a whole population, or specifically the population of neurons that project to the nucleus accumbens (NAc). Because the experiments here target various neuron populations in the VTA, this complicates the understanding and the interpretation of results in the context of a heterogeneous population of VTA DA neurons.

The VTA contains a heterogeneous population of DA neurons with respect their projection targets and HCN channel expression. Specifically, neurons that project to the nucleus accumbens (NAc) exhibit large HCN currents, whereas those that project to the prefrontal cortex do not. However, in [Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and 8, the authors seemingly record from the entire VTA population, while in [Figures 4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, and 6, they specifically target the NAc-projecting population, which exhibit large HCN currents. (Note: in the [Figure 3B](#fig3){ref-type="fig"} legend, it states that the recordings are from NAc-projecting neurons, but this is not discussed in the text describing these experiments.) Therefore, the rationale for this experimental design is unclear.

This confusion does not allow for a clear understanding and assessment of the novelty of this work, especially in relationship to the paper by Friedman et al., 2014, which also deals with Ih and VTA neuronal excitability in another stress paradigm. This paper shows several different and similar results to this paper. Although the authors mention this paper several times, the rationale for their experimental design (cell types etc.) and the discussion of their results is not clear; therefore, I was unable to form a clear picture on the role of VTA HCN channels in behavioral responses to chronic stress.

Reviewer \#2:

This manuscript examines the regulation of dopamine neurons that project to a specific area of the nucleus accumbens in control and following treatment of animals with manipulations that induce chronic stress. The results show that the animals show signs of stress induce depression, the activity of dopamine neurons is decreased and there is a reduction in I-h. Decreasing I-h with sh-RNA results in depressive like behaviors and expressing I-h prevents the depressive like behaviors.

1\) This is careful work looking at dopamine neurons using appropriate models and the inclusion of projection specific neurons.

2\) There are a few details that should be included in the manuscript. One easy and important addition is the inclusion of the resting conductance of the neurons. Those results are surely available. The reason for this request is based on the figures illustrating the differences in I-h. The conductance of the cells illustrated in [Figure 4](#fig4){ref-type="fig"} are very different. Likewise there is a huge difference in the conductance of the cells illustrated in [Figure 6](#fig6){ref-type="fig"}. These may just be bad examples but having a table of the conductance's would be very helpful.

3)The capacitance of the dopamine cells (50 pS) is about twice that which is often reported. How was the capacitance of the cells measured? What were the setting for the acquisition and filtering frequencies?

4\) The Results section measuring the sag of membrane potential are really not necessary and should be removed.

5\) There is a considerable amount of discussion in the results that is repeated in the discussion. The Results section could be edited to remove most of that and the manuscript would be more readable.

Reviewer \#3:

In this study Zhong and colleagues examine the biophysical mechanisms underlying CMS-induced depressive phenotype in mice. This is a potentially important study. Hence, it provides the first clear demonstration of a critical role of HCN2 in dynamically shaping NAc-projecting VTA DA AP firing activity in CMS mouse model by combining in vivo and ex vivo electrophysiology, and virus-mediated knockdown/overexpression of HCN2 in the lateral VTA. The manuscript is well-organized, clearly and thoroughly written, and the level of technical detail is appropriate.

I have a couple of concerns and suggestions listed below.

First, based on their findings the authors suggest that a reduced excitatory tone might contribute to the decreased DA AP firing in vivo. However, a reduction in both frequency and amplitude of mEPSCs together with a decreased AMPA/NMDA ratio is not as convincing as they state, since it is suggestive of other postsynaptic mechanisms to be involved rather than HCN2 solely. A paired pulse protocol and a measure of CV might add potential insights for the identification of this mouse phenotype.

Second, since the Authors found a reduced population activity they should cite the article by Moreines et al., (2017) where the same effect is observed in a CMS model but only in a subpopulation of VTA DA cells. Additionally, because of the \"laterality\" issue raised by Moreines et al. they should also discuss the location of their recorded DA cells (both ex vivo and in vivo). Finally, they could add a figure (or a table/panel) with their recording sites. This will add critical value to the study especially in light of the heterogeneity of VTA DA cells. Specie-specific effects might be also taken into account and discussed.

10.7554/eLife.32420.025

Author response

> Essential revisions:
>
> 1\) In their current state, the experiments studying synaptic parameters (i.e. minis, AMPA/NMDA ratio...) are: (1) per se not sufficient to provide mechanistic insights (2) rather confusing (see reviewers\' comments) (3) not sufficiently discussed. Thus, we advise that you remove this data set (and the corresponding discussion) from your revision. Alternatively, although it is not the reviewer\'s preferred option, the authors may choose performing all additional experiments suggested by the reviewers in their detailed reviews.
>
> Also, for the sake of clarity, the Results section measuring the sag of membrane potential are really not necessary and should be removed.

We have removed the experiments studying synaptic parameters (original [Figure 3B-E](#fig3){ref-type="fig"}), membrane potential sag (original [Figure 4H,I](#fig4){ref-type="fig"}), and the corresponding discussions.

> 2\) The VTA contains a heterogeneous population of DA neurons with respect to their projection targets and HCN channel expression. Specifically, neurons that project to the nucleus accumbens exhibit large HCN currents, whereas those that project to the prefrontal cortex do not.

*It is imperative that the authors analyze (Results section) and interpret (Discussion section) their results in light of the different target populations and different cell types that were identified in the VTA. Notably, the paper by Friedman et al., 2014 where Ih and VTA neuronal excitability were studied in another stress paradigm and the article by Moreines et al., (2017) where reduced activity was observed in a subpopulation of VTA DA cells in a CMS model, must be discussed. Additionally, because of the \"laterality\" issue raised by Moreines et al., the authors are requested to document and discuss the location of the recorded DA cells (both* ex vivo *and* in vivo).

The reviewer is correct that the VTA contains a heterogeneous population of dopamine neurons in regard to many aspects, including projection targets and HCN expression. Given that HCN current is the focus of our present study, our in vivo and ex vivo recordings targeted the lateral parabrachial pigmented area (PBP) of the VTA, where dopamine neurons exhibit large HCN currents, predominantly project to the lateral shell of the NAc and play a primary role in reward and motivated behavior. Our ex vivo recordings were made from NAc lateral shell-projecting DA neurons labelled with retrobeads, which were predominantly located in the lateral PBP of the VTA, consistent with Lammel et al., (2008, 2011). We also made efforts to target DA neurons in the lateral PBP in our in vivo recordings. The coordinates used for in vivo recordings (AP -2.9 to -3.3 mm, ML 0.6 to 1.1 mm, DV -3.9 to -4.5 mm) correspond to the PBP (mainly lateral PBP) but not in midline nuclei such as the interfascicular nucleus and the rostral linear nucleus, nor A10 DA neurons in the supramammillary nucleus. The location of some neurons was confirmed by juxtacellular labeling with neurobiotin and TH staining, with one neuron labeled in each mouse. To clarify the location of recorded DA neurons, we have revised the manuscript to more explicitly state that recordings were targeted to the lateral PBP.

Additionally, we provide a clearer rationale for targeting the lateral PBP and NAc lateral shell-projecting DA neurons, and better discuss our results in the context of VTA DA neuron heterogeneity. We specifically addressed the "laterality" issue raised in the Moreines et al. study. We suspect that differences in CMS paradigms and animal species might explain why Moreines et al. did not observe alterations in lateral VTA dopamine neuron firing. In addition, we have further discussed our results in the context of Friedman et al., 2014. In particular, we discuss effects on I~h~ current in DA neurons that project to different targets, and discuss the circuit-specific effects on HCN overexpression on depressive-like behavior. Further, we make clear the limitations of our viral knockdown and overexpression approaches, and discuss opportunities for future investigation into cell- and circuit-specific contributions of HCN2 channels in depressive- and anxiety-like behavior.

> 3\) The revised version must include the following technical details:
>
> -The resting conductance of the neurons must be provided in a table. The conductance of the cells illustrated in [Figure 4](#fig4){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"} are very different.

We analyzed the instantaneous current (I~ins~) in traces of I~h~ current in [Figure 4](#fig4){ref-type="fig"} and [Figure 6](#fig6){ref-type="fig"}, and plotted this current against the hyperpolarizing voltage steps. The slope of these I-V curves provides an approximation of the resting membrane conductance (G~resting~) (the measurement of G~resting~ has been shown in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). We find that there was not a significant effect of CMS on resting membrane conductance compared to control ([Figure 4G](#fig4){ref-type="fig"}). However, HCN2 knockdown with shRNA reduced resting membrane conductance compared to scramble-shRNA ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We have replaced traces for I~h~ current in [Figures 4](#fig4){ref-type="fig"} and [6](#fig6){ref-type="fig"} that better represent the averaged data. We have described the design and interpretation of the resting membrane conductance in the Materials and methods, Results and Discussion sections.

> -The capacitance of the dopamine cells (50 pS) is about twice that which is often reported. How was the capacitance of the cells measured? What were the setting for the acquisition and filtering frequencies?

VTA dopamine neurons have a relatively large cell body compared with many other cell types. We performed a literature search to determine what previous studies have measured for the capacitance of VTA dopamine neurons in mice. We find that the capacitance we recorded (control, \~51 pF; CMS, \~45 pF) is consistent with published studies (Chung et al., 2017, PMID: 28894175; Baimel et al., 2017, PMID: 28178514; Zhang et al., 2010, PMID: 20600174). Chung et al., (2017) reported the capacitance for VTA dopamine neurons to be \~50-60 pF. Baimel et al., (2017) reported differences in VTA dopamine neuron capacitance for different projection-defined dopamine neurons. Consistent with our result, the average capacitance for NAc lateral shell-projecting DA neurons was 57 pF. Although other populations had lower capacitances (24 pF for NAc medial shell-projecting; 38 pF for BLA-projecting), our recordings focused on NAc lateral shell-projecting neurons. In a third study, Zhang et al., (2010) report a capacitance of 79 pF for VTA DA neurons in the lateral VTA and 54 pF in the medial VTA. Thus, our result does not differ substantially from published studies. Membrane capacitance was measured by Clampex software using small amplitude hyperpolarizing and depolarizing steps ( ± 5 mV). As mentioned in the Materials and methods section, signals were sampled at 10 kHz and filtered at 2 kHz.

> -In the figure legends, the statements of the number of n per group are not clear. For example, in [Figure 2E](#fig2){ref-type="fig"}, it states \"n=10-13 neurons from 4-5 mice\". Does this mean 4-5 mice per group (control vs CMS), or combined between both groups?

In each relevant figure legend, we have clarified the numbers of neurons and mice in each group to avoid confusion.

> -The authors state that the C57BL/6 mice and the DAT-tdTomato mice did not show significant differences in their behavioral tests, so the results were pooled. The authors should show supplementary data to demonstrate this claim.

We now provide [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} presenting this data and [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"} for statistical analysis of this data.

[^1]: Division of Neurobiology, Department of Molecular and Cell Biology, Helen Wills Neuroscience Institute, University of California, Berkeley, United States.
